The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer

The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer

Introduction. Breast cancer is the most frequent malignant disease in women with about 25% compared to all malignant tumours. Chemotherapy, antiestrogen and ovarian ablation/ supression present effective adjuvant approach for premenopausal women diagnosed with hormonal depended, operable breast c...

Full description

Bibliographic Details
Main Authors:	Murtezani Zafir, Nešković-Konstantinović Zora, Stanisavljević Nataša, Kovčin Vladimir
Format:	Article
Language:	English
Published:	Serbian Medical Society 2011-01-01
Series:	Srpski Arhiv za Celokupno Lekarstvo
Subjects:	breast cancer premenopause ovarians
Online Access:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2011/0370-81791106339M.pdf

Similar Items

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer
by: V. F. Semiglazov, et al.
Published: (2018-11-01)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
by: Yen-Shen Lu, et al.
Published: (2021-09-01)

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
by: Yukinori Ozaki, et al.
Published: (2023-02-01)

Lipidome of mammographic breast density in premenopausal women
by: Kayla R. Getz, et al.
Published: (2023-10-01)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
by: Giacomo Pelizzari, et al.
Published: (2018-09-01)

Efficacy and safety of goserelin combined with adjuvant chemotherapy in premenopausal women with breast cancer
by: Yang Wang, et al.
Published: (2015-11-01)

Importance of evaluation of ovarian function in women with breast cancer when using endocrinotherapy
by: I. B. Kononenko, et al.
Published: (2018-07-01)

Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy for breast cancer in premenopausal patients. Pilot study results
by: I. B. Kononenko, et al.
Published: (2018-11-01)

Association of overweight and obesity with breast cancer during premenopausal period in Asia: A meta-analysis
by: Ricvan Dana Nindrea, et al.
Published: (2019-01-01)

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
by: Cynthia Villarreal-Garza, et al.
Published: (2021-10-01)

Coffee, Tea, and Mammographic Breast Density in Premenopausal Women
by: Adashi Margaret Odama, et al.
Published: (2021-10-01)

Comparison of Histopathologic Features of Endometrial Cancer Based on Menopausal Status and Safety of Ovarian Preservation in Premenopausal Women
by: Ozgur Kan, et al.
Published: (2017-07-01)

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases
by: Jiang Zhu, et al.
Published: (2023-02-01)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
by: Giuseppe Buono, et al.
Published: (2022-10-01)

ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01)

Adolescent and early adulthood inflammation-associated dietary patterns in relation to premenopausal mammographic density
by: Nichole A. Garzia, et al.
Published: (2021-07-01)

Efficacy and safety of adjuvant ovarian suppression with Buserelin-depo in premenopausal women with hormone-positive breast cancer
by: L. K. Ovchinnikova, et al.
Published: (2019-06-01)

Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01)

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer
by: Eleni Zografos, et al.
Published: (2022-07-01)

Association between Family History of Breast Cancer and Breast Density in Saudi Premenopausal Women Participating in Mammography Screening
by: Ibrahem Hussain Kanbayti, et al.
Published: (2024-01-01)

Hyperplastic processes of the endometrium in premenopausal women: modern opportunities of hormonal correction and prevention
by: L V Tkachenko, et al.
Published: (2013-04-01)

Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?
by: Favour A. Akinjiyan, et al.
Published: (2021-11-01)

The influence of obesity on folate status, DNA methylation and cancer-related gene expression in normal breast tissues from premenopausal women
by: Armina-Lyn M. Frederick, et al.
Published: (2021-04-01)

Inclusion of premenopausal women in breast cancer clinical trials
by: Kelsey L. Corrigan, et al.
Published: (2022-12-01)

Breast Cancer: Impact of Modifiable and Non-Modifiable Risk Factors Among Premenopausal Women of Karachi, Sindh
by: Mehir un Nisa Iqbal, et al.
Published: (2023-06-01)

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea
by: Hee Kyung Kim, et al.
Published: (2019-01-01)

A Study to Evaluate Risk of Ovarian Malignancy Algorithm (ROMA) in Patients with Ovarian Masses
by: Asna Aafreen, et al.
Published: (2022-07-01)

Premenopausal osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2013-01-01)

Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
by: Abdel-Razeq H
Published: (2019-05-01)

Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program
by: Nicoletta Staropoli, et al.
Published: (2022-09-01)

Impact of Body Composition on the Quality of Life of Premenopausal Patients with Early Stage Breast Cancer During Chemotherapy
by: Mirjana Pavlović Mavić, et al.
Published: (2022-01-01)

Chemotherapy-Induced Amenorrhea and Its Prognostic Significance in Premenopausal Women With Breast Cancer: An Updated Meta-Analysis
by: Yifei Wang, et al.
Published: (2022-04-01)

Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
by: Zhen-Yu Wu, et al.
Published: (2021-04-01)

Association between cadmium and anti-Mullerian hormone in premenopausal women at particular ages
by: Yu min Lee, et al.
Published: (2018-07-01)

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
by: Yiqun Li, et al.
Published: (2022-02-01)

Does Diet Offset the Effect of Veiling on Bone Mineral Density of premenopausal Indian women
by: Seema Kapoor, et al.
Published: (2015-01-01)

A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis
by: Jin Hong, et al.
Published: (2020-07-01)

Anthropometry, bone mineral density and risk of breast cancer in premenopausal and postmenopausal Saudi women
by: Nora AlFaris, et al.
Published: (2020-09-01)

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
by: Livianna Carrieri, et al.
Published: (2022-05-01)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
by: Yi-Kun Kang, et al.
Published: (2021-12-01)